🇺🇸 NaHCO3 in United States

67 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 67

Most-reported reactions

1. Anaemia — 9 reports (13.43%)
2. Euglycaemic Diabetic Ketoacidosis — 8 reports (11.94%)
3. Vomiting — 8 reports (11.94%)
4. Pyrexia — 7 reports (10.45%)
5. Thrombocytopenia — 7 reports (10.45%)
6. Cardiac Arrest — 6 reports (8.96%)
7. Drug Clearance Decreased — 6 reports (8.96%)
8. Renal Failure Acute — 6 reports (8.96%)
9. Pneumonia — 5 reports (7.46%)
10. Septic Shock — 5 reports (7.46%)

Source database →

Frequently asked questions

Is NaHCO3 approved in United States?

NaHCO3 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for NaHCO3 in United States?

Karadeniz Technical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.